← Leaderboards
Michal Laniado Schwartzman
New York Medical College
$18,004,835
Attributed
$18,004,835
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,009,879 · 9
By mechanism
P01$25,493,721 · 6
R01$8,516,158 · 3
Top collaborators
No co-investigators on record.
Most similar at New York Medical College
Same institution · by research overlap
- An Huang$3,671,713
- Alberto Nasjletti$6,905,477
- Mong-Heng Wang$2,184,581
- Victor Garcia$164,000
Others in their field
Top investigators on “Cytochrome P450”
- Eric F Johnson · Scripps Research Institute$21,555,814
- Irina A Pikuleva · University Of Texas Medical Br Galveston$15,661,223
- Maria Almira Correia · University Of California San Francisco$15,613,829
- Bhagavatula Moorthy · Baylor College Of Medicine$14,960,433
- Kafait U Malik · University Of Tennessee Health Sci Ctr$14,014,312
- Thomas Lewis Poulos · University Of California Irvine$13,657,191
Research focus
Cytochrome P450EicosanoidsBaseMediatingCellsProgramsTissuesHypertensionProductionProteinsBlood PressureIn VivoPlayBlood VesselsOverexpressionInflammatoryHydroxyeicosatetraenoic AcidsEndothelial CellsResearch PersonnelInflammationHormone RegulationFunctional DisorderMolecularSignal Transduction
Grant awards (52)
GPR75 in obesity-driven cardiovascular and metabolic complications$567,171
R01 · FY2025 · HL · contact PI
GPR75 in obesity-driven cardiovascular and metabolic complications$555,828
R01 · FY2024 · HL · contact PI
GPR75 in obesity-driven cardiovascular and metabolic complications$567,171
R01 · FY2023 · HL · contact PI
Molecular Mechanisms of 20-HETE-mediated Vascular Dysfunction and Hypertension$570,314
R01 · FY2021 · HL · contact PI
Molecular Mechanisms of 20-HETE-mediated Vascular Dysfunction and Hypertension$687,846
R01 · FY2020 · HL · contact PI
Molecular Mechanisms of 20-HETE-mediated Vascular Dysfunction and Hypertension$750,714
R01 · FY2019 · HL · contact PI
Molecular Mechanisms of 20-HETE-mediated Vascular Dysfunction and Hypertension$586,314
R01 · FY2018 · HL · contact PI
Molecular Mechanisms of 20-HETE-mediated Vascular Dysfunction and Hypertension$62,868
R01 · FY2018 · HL · contact PI
HORMONAL REGULATION OF BLOOD PRESSURE$2,201,085
P01 · FY2015 · HL · contact PI
20-HETE-Dependent Hypertension: Role of RAS$440,850
P01 · FY2015 · HL · contact PI
Administrative Core$353,374
P01 · FY2015 · HL · contact PI
Gene Vector and Animal Core$347,606
P01 · FY2015 · HL · contact PI
HORMONAL REGULATION OF BLOOD PRESSURE$2,251,547
P01 · FY2014 · HL · contact PI
20-HETE-Dependent Hypertension: Role of RAS$449,552
P01 · FY2014 · HL · contact PI
Administrative Core$362,519
P01 · FY2014 · HL · contact PI
Gene Vector and Animal Core$356,781
P01 · FY2014 · HL · contact PI
HORMONAL REGULATION OF BLOOD PRESSURE$2,181,569
P01 · FY2013 · HL · contact PI
20-HETE-Dependent Hypertension: Role of RAS$378,354
P01 · FY2013 · HL · contact PI
Administrative Core$373,212
P01 · FY2013 · HL · contact PI
Gene Vector and Animal Core$318,816
P01 · FY2013 · HL · contact PI
HORMONAL REGULATION OF BLOOD PRESSURE$2,285,707
P01 · FY2012 · HL · contact PI
20-HETE-Dependent Hypertension: Role of RAS$458,082
P01 · FY2012 · HL · contact PI
Administrative Core$369,274
P01 · FY2012 · HL · contact PI
Gene Vector and Animal Core$363,419
P01 · FY2012 · HL · contact PI
HORMONAL REGULATION OF BLOOD PRESSURE$19,212
P01 · FY2012 · HL · contact PI
HORMONAL REGULATION OF BLOOD PRESSURE$2,248,247
P01 · FY2011 · HL · contact PI
20-HETE-Dependent Hypertension: Role of RAS$447,563
P01 · FY2011 · HL · contact PI
Administrative Core$373,505
P01 · FY2011 · HL · contact PI
Gene Vector and Animal Core$352,901
P01 · FY2011 · HL · contact PI
"Corneal Arachidonate Metabolites via Cytochrome P450"$382,114
R01 · FY2010 · EY · contact PI
Hormonal Regulation of Blood Pressure$2,464,863
P01 · FY2009 · HL · contact PI
Role of 20-HETE in Endothelial Dysfunction$517,806
P01 · FY2009 · HL · contact PI
"Corneal Arachidonate Metabolites via Cytochrome P450"$403,767
R01 · FY2009 · EY · contact PI
"Corneal Arachidonate Metabolites via Cytochrome P450"$385,973
R01 · FY2009 · EY · contact PI
Hormonal Regulation of Blood Pressure$2,352,814
P01 · FY2008 · HL · contact PI
Role of 20-HETE in Endothelial Dysfunction$494,272
P01 · FY2008 · HL · contact PI
"Corneal Arachidonate Metabolites via Cytochrome P450"$378,253
R01 · FY2008 · EY · contact PI
Role of 20-HETE in Endothelial Dysfunction$492,249
P01 · FY2007 · HL · contact PI
"Corneal Arachidonate Metabolites via Cytochrome P450"$383,950
R01 · FY2007 · EY · contact PI
Corneal Arachidonate Metabolites via Cytochrome P450$395,000
R01 · FY2006 · EY · contact PI
Role of 20-HETE in Endothelial Dysfunction$337,097
P01 · FY2006 · HL · contact PI
Corneal Arachidonate Metabolites Cytochrome P-450$352,125
R01 · FY2005 · EY
Role of 20-HETE in Endothelial Dysfunction$327,280
P01 · FY2005 · HL
Corneal Arachidonate Metabolites Cytochrome P-450$352,125
R01 · FY2004 · EY
Corneal Arachidonate Metabolites Cytochrome P-450$352,125
R01 · FY2003 · EY
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS$314,833
P01 · FY2003 · HL
Corneal Arachidonate Metabolites Cytochrome P-450$391,250
R01 · FY2002 · EY
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS$314,833
P01 · FY2002 · HL
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS$314,833
P01 · FY2002 · HL
Corneal Arachidonate Metabolites Cytochrome P-450$391,250
R01 · FY2001 · EY
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS$314,833
P01 · FY2001 · HL
FUNCTION AND REGULATION OF CYTOCHROME P450 4A ISOFORMS$314,833
P01 · FY2000 · HL